<DOC>
	<DOCNO>NCT01448889</DOCNO>
	<brief_summary>Acute renal failure induce radiographic contrast agent know complication coronary angiography.hypoxia play major role pathogenesis Contrast induce nephropathy . The aim current study investigate effect normobaric hyperoxygenation therapy renal function patient high risk CIN undergo coronary angiography . The study aim include 180 consecutive patient estimate GFR base MDRD equation le 60 mL/min/1.73 m2 candidate elective coronary angiography . Patients acute renal failure , acute myocardial infarction , noncompensated congestive heart failure , hemodynamic instability , know sensitivity contrast medium patient expose contrast medium last 3 month exclude . Patients oxygen blood saturation le 94 % room air also exclude study . Study protocol Patients randomly assign receive either 100 % oxygen mask ( treat group ) breath room air ( control group ) duration 4 hour start begin angiographic procedure . All patient treat 0.9 % salin NAC . Coronary angiography perform use nonionic , low osmolar iodine ( Ultravist®-370 ) ( Schering , Berlin , Germany ) . All patient hospitalize 1 day least 24 hour follow angiography . Blood sample urea , creatinine cystatin- C drawn admission , 6 , 24 48 hour coronary angiography . Urine sample take 24 hour angiography 6 , 24 48 hour post angiography . In urine sample ratio creatinine Isoprostanes NO evaluate .</brief_summary>
	<brief_title>Normobaric Hyperoxygenation Prevention Contrast Induced Nephropathy</brief_title>
	<detailed_description>Acute renal failure induce radiographic contrast agent know complication coronary angiography . It demonstrate follow contrast medium application renal outer medullar blood flow reduce , result medullar ischemia . N-acetylcysteine ( NAC ) together well hydration stand center treatment prevent contrast induce nephropaathy ( CIN ) . Since , hypoxia play major role pathogenesis CIN seem rational increase oxygen delivery renal tissue ameliorate expect CIN . The aim current study investigate effect normobaric hyperoxygenation therapy renal function patient high risk CIN undergo coronary angiography . The study protocol approve local Ethics Committee patient give write informed consent include study . The study aim include 180 consecutive patient estimate GFR base MDRD equation le 60 mL/min/1.73 m2 candidate elective coronary angiography . Patients acute renal failure , acute myocardial infarction , noncompensated congestive heart failure , hemodynamic instability , know sensitivity contrast medium patient expose contrast medium last 3 month exclude . Patients oxygen blood saturation le 94 % room air also exclude study . Study protocol Patients randomly assign receive either 100 % oxygen mask ( treat group ) breath room air ( control group ) duration 4 hour start begin angiographic procedure . All patient treat 0.9 % salin NAC . Saline o.9 % hydration infuse rate 1 mL/kg/hour 12 hour 12 hour coronary angiography . NAC 1g [ Mucomyst 20 % solution ( Bristol-Meyers , New York , NY , USA ) ] administer orally twice daily 24 hour 24 hour coronary angiography . Coronary angiography perform use nonionic , low osmolar iodine ( Ultravist®-370 ) ( Schering , Berlin , Germany ) . All patient hospitalize 1 day least 24 hour follow angiography . Blood sample urea , creatinine cystatin- C drawn admission , 6 , 24 48 hour coronary angiography . Urine sample take 24 hour angiography 6 , 24 48 hour post angiography . In urine sample ratio creatinine Isoprostanes NO evaluate . Laboratory analysis Two 10mL aliquot urine collection separate stored -70°C analyze nitric oxide metabolite urinary isoprostanes . Measurement urinary nitric oxide metabolites Metabolites nitric oxide ( NOx ) ( NO2+ NO3 ) measure urine sample . Total NO synthesis evaluate duplicate , specific two-step photocolorimetric assay ( R &amp; D Systems , USA ) protocol supply manufacturer . The intensity develop color measure ELISA reader , 540 nm wavelength . Oxidative stress Oxidative stress assess measurement urinary isoprostanes , secondary end product lipid peroxidation know accurate sensitive marker renal oxidative stress vivo . STAT-8 isoprostane PGF2 content estimate specific EIA ( Cayman Chemical Co. , Ann Arbor , Mich. , USA ) base competition 8-isoprostane 8-isoprostane-alkaline phosphatase conjugate limit number specific STAT-8 isoprostane PGF2 antibody bind site subsequent reaction immobilize complex p-nitrophenyl-phosphate . The intensity develop yellow color measure ELISA reader 405 nm wavelength . Investigators involve measurement blood urea , creatinin cystatin-C urinary NOx isoprostanes blind patient ' treatment . Statistical analysis The calculation sample size base follow assumption : Baseline frequency CIN 20 % , least 35 % reduction control group , alpha error level 5 % , beta error level 50 % expect drop rate 15 % . Continuous baseline variable compare treatment group unpaired test pair test within group . Categorical parameter compare chi-square test . The effect oxygen therapy serum urea , creatinine , serum urea , serum cystatin-C , urinary NOx , urinary isoprostanes baseline 6 , 24 48 hour follow angiography compare group general linear model repeated-measures analysis variance ( ANOVA ) . The statistical software SPSS ( version 13.0 , SPSS , Inc. , Chicago , IL , USA ) use analysis . All test two tail . P value 0.05 consider significant . Data express mean SEM .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>elective coronary angiography estimate GFR base MDRD equation le 60 mL/min/1.73 m2 inform consent acute renal failure acute myocardial infarction noncompensated congestive heart failure hemodynamic instability know sensitivity contrast medium patient expose contrast medium last 3 month Patients oxygen blood saturation le 94 % room air .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>contrast induce nephropathy</keyword>
	<keyword>oxigen</keyword>
	<keyword>coronary angiography</keyword>
</DOC>